Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
The effect of B-cell depletion in the Theiler's model of multiple sclerosis.
Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.
Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.
A Limited Form of Neuromyelitis Optica With a Lesion of the Fourth Nerve Nucleus.
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Vaccines in Multiple Sclerosis.
Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.
Brain cytokines and disease.
[Actual medical care situation and therapeutic needs in multiple sclerosis : Impact of the Pharmaceutical Market Restructuring Act (AMNOG)].
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.
VZV encephalitis that developed in an immunized patient during fingolimod therapy.
Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.
Chronic inflammatory demyelinating polyneuropathy associated with alopecia totalis and Sjögren syndrome.
Progressive cerebral atrophy in neuromyelitis optica.
Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany.
Microglia-Mediated Inflammation and Neurodegenerative Disease.
Anxiety, depression and fatigue at 5-year review following CNS demyelination.
Axon growth inhibition by RhoA/ROCK in the central nervous system.
[The application of high-frequency and iTBS transcranial magnetic stimulation for the treatment of spasticity in the patients presenting with secondary progressive multiple sclerosis].
Dystonic pattern in a fibromyalgia patient: Relevance of a biopsychosocial rehabilitation approach.
Another Case of PML with Gilenya Reported by Novartis
Role of executive functions in prospective memory in multiple sclerosis: Impact of the strength of cue-action association.
Multi-channel registration of fractional anisotropy and T1-weighted images in the presence of atrophy: application to multiple sclerosis.
MSRV envelope protein is a potent, endogenous and pathogenic agonist of human toll-like receptor 4: Relevance of GNbAC1 in multiple sclerosis treatment.
Pages
« first
‹ previous
…
709
710
711
712
713
714
715
716
717
…
next ›
last »